1. GLUC's CEO and CFO resigned effective September 30, 2025, for personal reasons. 2. Murray Fleming will temporarily oversee CEO and CFO roles. 3. Company faces uncertain prospects with limited operating capital. 4. Operations will continue under existing oversight, but challenges remain.
Leadership resignations often signal instability, potentially affecting investor confidence. Historical examples show that similar events lead to stock price declines.
Leadership stability is critical for investor confidence; a sudden change raises concerns about direction and operational continuity.
Short-term volatility expected as market reacts to leadership changes. Prior instances where companies experience management upheaval show immediate price adjustments.
BENTONVILLE, Ark., Sept. 26, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced that its Chief Executive Officer and Chief Financial Officer has resigned, effective September 30, 2025, for personal reasons. The resignation was not requested by the Company.
Murray Fleming, the Company's sole Director, will perform the functions of Chief Executive Officer and Chief Financial Officer in his capacity as Director to provide administrative continuity and will assist shareholders in identifying new officers. This service will continue until one of the following occurs:
There were no disagreements with the Company on any matter relating to its operations, policies, or practices.
The Company confirms that day-to-day operations will continue under the Director's oversight; however, the Company has limited operating capital and uncertain prospects to continue as a going concern.
For further information, please contact:
info@glucosehealthinc.com
